IL147023A0 - Stable xylometazoline and oxymetazoline solution - Google Patents

Stable xylometazoline and oxymetazoline solution

Info

Publication number
IL147023A0
IL147023A0 IL14702300A IL14702300A IL147023A0 IL 147023 A0 IL147023 A0 IL 147023A0 IL 14702300 A IL14702300 A IL 14702300A IL 14702300 A IL14702300 A IL 14702300A IL 147023 A0 IL147023 A0 IL 147023A0
Authority
IL
Israel
Prior art keywords
oxymetazoline solution
xylometazoline
stable
stable xylometazoline
oxymetazoline
Prior art date
Application number
IL14702300A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23322017&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL147023(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of IL147023A0 publication Critical patent/IL147023A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Cosmetics (AREA)
IL14702300A 1999-06-22 2000-06-17 Stable xylometazoline and oxymetazoline solution IL147023A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33778999A 1999-06-22 1999-06-22
PCT/EP2000/005583 WO2000078297A2 (de) 1999-06-22 2000-06-17 Stabile xylometazolin- und oxymetazolinlösung

Publications (1)

Publication Number Publication Date
IL147023A0 true IL147023A0 (en) 2002-08-14

Family

ID=23322017

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14702300A IL147023A0 (en) 1999-06-22 2000-06-17 Stable xylometazoline and oxymetazoline solution

Country Status (22)

Country Link
US (2) US20040191177A1 (cs)
EP (1) EP1194145B1 (cs)
JP (1) JP2003502361A (cs)
KR (1) KR20020012001A (cs)
CN (1) CN1164271C (cs)
AT (1) ATE232099T1 (cs)
AU (1) AU765736B2 (cs)
BR (1) BR0011950A (cs)
CA (1) CA2376121C (cs)
CZ (1) CZ295595B6 (cs)
DE (1) DE50001217D1 (cs)
EA (1) EA003329B1 (cs)
ES (1) ES2188563T3 (cs)
HK (1) HK1045945B (cs)
HU (1) HUP0201700A3 (cs)
IL (1) IL147023A0 (cs)
MX (1) MXPA01012912A (cs)
PL (1) PL197542B1 (cs)
PT (1) PT1194145E (cs)
TR (1) TR200103694T2 (cs)
WO (1) WO2000078297A2 (cs)
ZA (1) ZA200110386B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL208686B1 (pl) * 2001-09-18 2011-05-31 Nycomed Danmark Aps Kompozycja w postaci roztworu wodnego do leczenia przeziębienia oraz zastosowanie połączenia ipratropium lub jego soli i ksylometazoliny lub jej soli
AU2003278962B2 (en) * 2002-06-20 2006-11-23 Novartis Consumer Health S.A. Nasal compositions comprising a mucopolysaccharide and propylene glycol
AU2003272517A1 (en) * 2002-09-13 2004-04-30 Zicam, Llc. Compositions to reduce congestion and methods for application thereof to the nasal membrane
DE10337186A1 (de) * 2003-08-13 2005-03-17 Merck Patent Gmbh Wässrige Wirkstoff-Lösung
US20090136598A1 (en) * 2006-04-26 2009-05-28 Aciex, Inc. Compositions for the Treatment and Prevention of Eyelid Swelling
MX2008013783A (es) * 2006-04-26 2009-02-05 Aciex Inc Composiciones para el tratamiento y prevención de la hinchazón de los párpados.
CN101912363A (zh) * 2010-07-29 2010-12-15 蔡海德 溶解超滤-喷雾干燥-分子分散包衣-水化制粒-冷冻干燥生产脂质体组合药物
CN107249566A (zh) 2014-12-24 2017-10-13 加德兰-盖林斯基实验室有限责任公司 一种以海水作为赋形剂提高稳定性的鼻用组合物
ES3039833T3 (en) 2021-09-22 2025-10-24 Jadran Galenski Laboratorij D D An improved pharmaceutical composition for nasal use, preparation, and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603131A (en) * 1982-04-26 1986-07-29 Bernstein Joel E Method and composition for treating and preventing irritation of the mucous membranes of the nose
US4970240A (en) * 1989-10-18 1990-11-13 Schering Corporation Fruity flavored nasal decongestant composition
US5114979A (en) * 1989-10-18 1992-05-19 Schering Corporation Fruity flavored nasal decongestant composition
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
DE19549421C2 (de) * 1995-11-10 1999-11-18 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
US6053368A (en) * 1995-11-17 2000-04-25 Ursatec Verpackung-Gmbh Anti-contamination dispensing apparatus for fluids
DE19542959C1 (de) * 1995-11-17 1996-10-24 Ursatec Verpackung Gmbh Vor Kontamination schützende Abgabevorrichtung für Fluide
ATE219657T1 (de) * 1998-01-30 2002-07-15 Novartis Consumer Health Sa Nasale lösungen

Also Published As

Publication number Publication date
AU765736B2 (en) 2003-09-25
DE50001217D1 (de) 2003-03-13
EP1194145B1 (de) 2003-02-05
CN1361689A (zh) 2002-07-31
HUP0201700A2 (hu) 2002-12-28
JP2003502361A (ja) 2003-01-21
ATE232099T1 (de) 2003-02-15
CN1164271C (zh) 2004-09-01
WO2000078297A3 (de) 2001-03-01
WO2000078297A2 (de) 2000-12-28
EA200200042A1 (ru) 2002-06-27
US20080011293A1 (en) 2008-01-17
EP1194145A2 (de) 2002-04-10
EA003329B1 (ru) 2003-04-24
AU6150600A (en) 2001-01-09
CZ295595B6 (cs) 2005-08-17
ZA200110386B (en) 2003-04-22
CA2376121C (en) 2008-06-10
CZ20014568A3 (cs) 2002-03-13
KR20020012001A (ko) 2002-02-09
HK1045945B (zh) 2005-01-28
PL352354A1 (en) 2003-08-11
HUP0201700A3 (en) 2003-02-28
PL197542B1 (pl) 2008-04-30
ES2188563T3 (es) 2003-07-01
US20040191177A1 (en) 2004-09-30
BR0011950A (pt) 2002-03-12
PT1194145E (pt) 2003-06-30
MXPA01012912A (es) 2002-09-18
HK1045945A1 (en) 2002-12-20
CA2376121A1 (en) 2000-12-28
TR200103694T2 (tr) 2002-04-22

Similar Documents

Publication Publication Date Title
DE60042550D1 (de) Mutierte varianten des insulin-ähnlichen wachstumsfaktor i (igf-i)
SG147286A1 (en) Manufacture of polyglumate-therapeutic agent conjugates
EP1406680A4 (en) BIOFUNCTIONAL FIBERS
EP1337206A4 (en) LIMBS MASS STABILISATOR
DE50012408D1 (de) Polyurethanlösungen mit alkoxysilanstruktureinheiten
EP1191911A4 (en) ORIENTED BIOPOLYMER MEMBRANE
MXPA03000136A (es) Derivados anticonvulsivos utiles para prevenir el desarrollo de la diabetes mellitus de tipo ii o del sindromex.
AU3597201A (en) Clear aqueous anaesthetic composition
AU2001268750A1 (en) Flushed-seal respirator
AU2002368228A8 (en) Micro-organism mail sterilizer
MXPA03009602A (es) Analogos de nociceptina.
IL147023A0 (en) Stable xylometazoline and oxymetazoline solution
IL137860A0 (en) Coronary membrane covered stent
BG106316A (en) Ambroxol-containing lozenge
WO2002024181A3 (en) The use of melatonin for induction of general anesthesia
PL357875A1 (en) Cyclic hexapeptide derivatives
AU2207801A (en) Substances
PL373734A1 (en) Mildew-resistant sealing compound formulations containing a benzothiophene-2-cyclohexylcarboxamide-s,s-dioxide
MXPA02004103A (es) Uso de los agonistas de los receptores para dopamina d3 para el tratamiento de hipertension dependiente de la sal.
DE69926019D1 (de) G.723.1 audiokodierer
AU1577302A (en) Hydrogen peroxide lyase regulatory region
AU150891S (en) Container
UA33933A (uk) Лімфогінний засіб
SI1154775T1 (en) Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol
AU2892P (en) Cloudy Days Agapanthus orientalis